Autopsy report · NCT05799066
Measuring Relative Afferent Pupillary Defect
Cause of deathStaffing, sites or logistics
“The study was terminated early for administrative reasons.”
Life of this trial
- Registered 1 month before it started.
- Ran for about 2 years 10 months before it stopped.
- 71 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- The University of Texas Medical Branch, Galveston
- Sponsor type
- University, hospital or other
- Conditions
- Relative Afferent Pupil Defect (RAPD)
- Interventions
- Swinging Light test; Virtual Reality Head-Mounted Display (VR HMD)
- Participants
- 71
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase
“This study was terminated early for administrative reasons.” - An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract Infections
“Study was prematurely terminated due to administrative and strategic reasons” - Sym004 Versus Futuximab or Modotuximab in Patients With mCRC
“Study was terminated due to administrative reasons” - Safety and Tolerability of PNT001 in Patients With Acute Traumatic Brain Injury (TBI)
“The study was terminated due to administrative, non-safety related reasons.” - PDR001 in Combination With Bevacizumab and mFOLFOX6 as First Line Therapy in Patients With Metastatic MSS Colorectal Cancer
“The study was terminated early due to company decision.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.